Search
for
Sort by
Research 541–570 of 1000+
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Combined hormonal contraception and venous thromboembolism
- Endocrine-skin interactions
- Thyroid hormone action on skin
- Fat, Stem Cells, and Platelet-Rich Plasma
- Evidence-based approach to cutaneous hyperandrogenism in women
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Hirsutism: Diagnosis and management
- The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata
- Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation
- Low sex-hormone binding globulin levels in young women with diffuse hair loss
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Circulatory Changes in Alopecia
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Interventions for female pattern hair loss
- Sex hormones and sarcopenia in older persons
- Stem cells and alopecia: a review of pathogenesis
- Madarosis
- Virilizing Adrenocortical Oncocytoma in a Child: A Case Report
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors
- Polycystic ovary syndrome: A review for dermatologists
- Progesterone, neurosteroids, and the hormonal basis of catamenial epilepsy
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.